Carbidopa/levodopa Interactions
There are 483 drugs known to interact with carbidopa/levodopa, along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 46 are major, 426 are moderate, and 11 are minor.
- View all 483 medications that may interact with carbidopa/levodopa
- View carbidopa/levodopa alcohol/food interactions (1)
- View carbidopa/levodopa disease interactions (12)
Most frequently checked interactions
View interaction reports for carbidopa / levodopa and the medicines listed below.
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Azilect (rasagiline)
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flomax (tamsulosin)
- Lasix (furosemide)
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Mirapex (pramipexole)
- Myrbetriq (mirabegron)
- Nexium (esomeprazole)
- Plavix (clopidogrel)
- Seroquel (quetiapine)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Carbidopa/levodopa alcohol/food interactions
There is 1 alcohol/food interaction with carbidopa / levodopa.
Carbidopa/levodopa disease interactions
There are 12 disease interactions with carbidopa / levodopa which include:
- glaucoma
- cardiac disease
- hypotension
- neuroleptic malignant syndrome
- psychoses/depression
- psychosis
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- depression
- GI bleeding
Report options
QR code containing a link to this page
More about carbidopa / levodopa
- carbidopa/levodopa consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (92)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dopaminergic antiparkinsonism agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
